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pared with those without GDM in a Chinese population.
Methods: Tianjin GDM observational study included 1263 women with a history of GDM and
705 women without GDM. Multivariate logistic regression was used to assess risks of post-
partum metabolic syndrome between women with and without GDM. Postpartum meta-
bolic syndrome was diagnosed by two commonly used criteria.
Results: During a mean 3.53 years of follow up, 256 cases of metabolic syndrome were iden-
tified by using the NCEPATPIII criteria and 244 cases by using the IDF criteria. Multivariable-
adjusted odds ratios of metabolic syndrome in women with GDM compared with those
without GDM were 3.66 (95% confidence interval [CI] 2.02–6.63) for NCEP ATPIII criteria
and 3.90 (95% CI 2.13–7.14) for IDF criteria. Women with GDM had higher multivariable-
adjusted odds ratios of central obesity, hypertriglyceridemia, and high blood pressure than
women without GDM. The multivariable-adjusted odds ratios of low HDL cholesterol and
hyperglycemia were not significant between women with and without GDM, however,
the multivariable-adjusted odds ratio of hyperglycemia became significant when we used
the modified criteria.
Conclusions: The present study indicated that women with prior GDM had significantly
higher risks for postpartum metabolic syndrome, as well as its individual components.
 2019 Elsevier B.V. All rights reserved.kins Road,
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Metabolic syndrome was firstly defined in 1988 as ‘‘Syndrome
X” [1]. The syndrome is characterized by a cluster of cardio-
vascular risk factors including visceral obesity, dyslipidemia,
hypertension and hyperglycemic, and insulin resistance.
The pathogenesis of the metabolic syndrome is complicated.
It has been proposed that the metabolic syndrome is a power-
ful determinant of type 2 diabetes and atherosclerotic cardio-
vascular disease [2–6].
Gestational diabetes mellitus (GDM) is a common preg-
nancy outcome affecting 7% of pregnancies in the US and
China [7–9]. Women with GDM would have a massive risk of
postpartum diabetes, as well as the related metabolic disor-
ders [10]. However, the diagnostic criteria of metabolic syn-
drome vary among different ethnics and ethnicities [11]. In
addition, very few studies have assessed the postpartum risk
of metabolic syndrome in the Asian population with GDM. In
this present study, we aimed to investigate the risk of post-
partum metabolic syndrome in women with GDM compared
with those without GDM in a large Chinese population.
2. Material and methods
2.1. Tianjin GDM screening project
Tianjin is the fourth largest city in China with only 30 min
away from the Capital Beijing by train. There are six central
districts in Tianjin with about 4.3 million residents. Since
1999, the Tianjin Women’s and Children’s Health Center
launched a universal screening of GDM using WHO’s criteria
in all six central districts [7]. The screening rate was reported
to be >91% between 1999 and 2008 [7]. We used a 1-hour glu-
cose screening test with 50 g glucose load at 26–30 gestational
weeks. If the 1-hour glucose level was over 7.8 mmol/L,
another 2-h oral glucose tolerance test (OGTT) with 75 g glu-
cose load would be performed at the Tianjin Women’s and
Children’s Health Center. GDM diagnosis was made as per
WHO criteria: a 75-g glucose 2-h OGTT result confirming
either diabetes (fasting glucose 7 mmol/l or 2-hour glucose
11.1 mmol/l) or impaired glucose tolerance (IGT) (2-hour glu-
cose 7.8 and <11.1 mmol/l) [12].
2.2. Study samples
Totally 76,325 women were screened from 2005 to 2009,
among whom 4644 women were diagnosed as GDM and
71,681 were free of GDM. We invited all 4644 GDM women to
participate in the Tianjin Gestational Diabetes Mellitus
Prevention Program (TGDMPP). Finally, 1263 women with
prior GDM finished the baseline survey including a question-
naire and an OGTT between August 2009 and July 2011.
Among the 1263 women, 83 were newly diagnosed diabetes
using an OGTTand 1180 GDMwomen received randomization
into the intervention group (n = 586) and the ‘‘usual care” con-
trol group (n = 594) for the TGDMPP [13–16]. In parallel, we
also enrolled in the Tianjin GDM observational study 705
non-GDM women and their children with birth dates and
sex frequency-matched to the 594 children of GDM womenin the ‘‘usual care” group and 83 children of GDM women
who were newly diagnosed diabetes at baseline survey [17].
The study was approved by the Human Subjects Committee
of the Tianjin Women’s and Children’s Health Center. All
the participants provided written informed consent.
2.3. Questionnaires and measurements
All study participants filled in a questionnaire about their
socio-demographics (age, marital status, education, income,
and occupation), history of GDM, family history (diabetes,
coronary heart disease, stroke, cancer and hypertension),
medical history (hypertension, diabetes, and hypercholes-
terolemia), pregnancy outcomes (pre-pregnancy weight,
weight gain in pregnancy, and number of children), dietary
habits (a self-administered food frequency questionnaire
(FFQ) to measure the frequency and quantity of intake of 33
major food groups and beverages during the past year) [18],
alcohol intake, smoking habits, passive smoking, and physi-
cal activity (the frequency and duration of leisure time and
sedentary activities) at the postpartum baseline survey. They
also completed the 3-day 24-hour food records using methods
for dietary record collections taught by a dietician. The perfor-
mance of 3-day 24-hour food records [18], the FFQ [18], and
the above questionnaire on assessing physical activity
[19,20] have been validated in the China National Nutrition
and Health Survey in 2002.
Specially trained research doctors measured body weight
and height using the standardized protocol. Body mass index
(BMI) was calculated as the body weight in kilograms divided
by the square of the height in meters. Waist circumference
was measured at the horizontal level between the inferior
costal margin and the iliac crest on the mid-axillary line with
women in their standing position. Blood samples were col-
lected in all participants after an overnight fast of at least
12 h. Participants without a self-reported history of diabetes
were given a standard 75-g glucose OGTT test. Plasma glucose
was measured on an automatic analyzer (Toshiba TBA-120FR,
Japan).
2.4. Definition of postpartum metabolic syndrome
Individuals were considered to have the metabolic syndrome
according to the International Diabetes Federation (IDF) defi-
nition [11] if they had central obesity (waist circumference
90 cm in men or 80 cm in women) plus at least two of
the following: (1) raised triglycerides >150 mg/dL (1.7 mmol/
L) or using specific treatment for this lipid abnormality; (2)
reduced high-density lipoprotein (HDL) cholesterol <40 mg/
dL (1.03 mmol/L) in men or <50 mg/dL (1.29 mmol/L) in
women or using specific treatment for this lipid abnormality;
(3) raised blood pressure (systolic 130 mmHg or diastolic
85 mmHg or using antihypertensive drugs); and (4) raised
fasting plasma glucose >100 mg/dL (5.6 mmol/L) or previously
diagnosed type 2 diabetes.
Individuals were considered to have the metabolic syn-
drome according to the National Cholesterol Education Pro-
gram Adult Treatment Panel III (NCEP ATPIII) criteria
modified by the American Heart Association/National Heart,
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of the following: (1) waist circumference 90 cm in men, or
80 cm in women; (2) systolic blood pressure 130 mmHg,
and/or diastolic blood pressure 85 mmHg, or using antihy-
pertensive drug treatment; (3) fasting glucose 100 mg/dL,
or using drug treatment for elevated glucose; (4) triglyceride
150 mg/dL or using drug treatment for elevated triglyc-
erides; (5) HDL cholesterol <50 mg/dL in women, or <40 mg/
dL in men, or using drug treatment for reduced HDL
cholesterol.
Since Chinese people were more likely to have postpran-
dial hyperglycemia probably due to more intake of carbohy-
drates than the people in western countries [21,22], we used
a modified criterion for hyperglycemia as either fasting glu-
cose 5.6 mmol/l or 2-h glucose 7.8 mmol/l or using
glucose-lowering agents.
2.5. Statistical analysis
Standard t test and chi-square test were used in the compar-
ison of continuous variables and categorical variables
between women with and without GDM. Multivariate logistic
regression analysis was used to assess the risk of postpartum
metabolic syndrome between women with and without GDM.
All analyses were adjusted for age (Model 1), and then for
postpartum years, weight gain during pregnancy, education,
family income, family history of diabetes, current smoking,
passive smoking, current alcohol drinking, leisure time phys-
ical activity, sleeping time, energy consumption, fiber, fat,
protein and carbohydrate consumption, and sweetened bev-
erage drinking (Model 2). P < 0.05 was considered statistically
significant. All statistical analyses were performed by IBM
SPSS Statistics for Windows, version 24.0 (IBM Corp., Armonk,
N.Y., USA).
3. Results
The flow chart of the overall study design can be seen in Fig. 1.
Baseline data of 1263 women with GDM and 705 without GDM
were used in the analysis. General characteristics of women
with and without GDM are presented in Table 1. Women with
GDMwere older at delivery, their antepartum and postpartum
BMI, HbA1c, fasting and 2-h glucose were much higher, and
they had less education years, less family income, were less
alcohol drinkers, less physically active and had more energy
intakes compared with women without GDM.
During a mean 3.53 years of follow up after delivery, 256
cases of metabolic syndrome were identified by using NCEP
ATPIII criteria and 244 cases by using IDF criteria.
Multivariable-adjusted (age at delivery, postpartum years,
weight gain during pregnancy, education, family income,
family history of diabetes, current smoking, passive smoking,
current alcohol drinking, leisure time physical activity, sleep-
ing time, energy consumption, fiber, fat, protein and carbohy-
drate consumption, and sweetened beverage drinking) odds
ratios of metabolic syndrome in women with GDM compared
with those without GDM were 3.66 (95% confidence interval
[CI] 2.02–6.63) for NCEP ATPIII criteria and 3.90 (95%CI 2.13–
7.14) for IDF criteria (Table 2). Multivariable-adjusted oddsratios of different individual components of metabolic syn-
drome were also calculated. Women with GDM had higher
multivariable-adjusted odds ratios of central obesity (2.64,
95% CI 1.75–3.98 for two criteria), hypertriglyceridemia (4.14,
95% CI 2.21–7.75 for NCEP ATPII criteria; 3.68, 95% CI 1.94–
6.97 for IDF criteria), and high blood pressure (3.60, 95% CI
1.79–7.25 for two criteria) than women without GDM. The
multivariable-adjusted odds ratios of low HDL cholesterol
and hyperglycemia were non-significant among women with
GDM compared with those without GDM, however, the
multivariable-adjusted odds ratio of hyperglycemia became
significant (1.62, 95% CI 1.08–2.44) when we used the modified
criteria for hyperglycemia.
Table 3 showed the association of GDM and the risk of
postpartum metabolic syndrome in different subgroups.
Multivariable-adjusted direct associations between the his-
tory of GDM and the risk of metabolic syndrome by two differ-
ent criteria were significant and persisted when stratified by
women younger and older than 30 years at delivery; younger
and older than 35 years at survey after delivery; normal
weight and overweight women after delivery; and pre-
pregnancy normal weight women. There were no significant
interactions of age at delivery, postpartum age, antepartum
BMI, and postpartum BMI and the history of GDM with the
risk of metabolic syndrome (all P for interaction >0.25).
In order to confirm the results, we further performed a
sensitivity analysis only including 594 women with GDM
who were assigned to the control group vs. women without
GDM. Similar results were seen in this sensitivity analysis
that women with GDM had higher risk of postpartum meta-
bolic syndrome by NCEP ATPIII criteria (2.79, 95%CI 2.00–
3.89) and its components when modified criteria of hyper-
glycemia was applied (central obesity, 2.50 (1.98–3.15); hyper-
triglyceridemia, 2.43 (1.65–3.60); high blood pressure, 1.63
(1.06–2.51); low HDL cholesterol, 1.68 (1.34–2.11); hyper-
glycemia 1.30 (1.03–1.65)).
4. Discussion
In this large study, we found an over threefold higher risk of
postpartum metabolic syndrome in Chinese women with
GDM compared with women without GDM, which was higher
than the risks reported previously. Women with GDM also
showed increased risks of central obesity, hypertriglyc-
eridemia, high blood pressure and hyperglycemia compared
with women without GDM.
Limited evidence supported a higher risk of postpartum
metabolic syndrome in women with GDM compared with
those without GDM. The ATLANTIC-DIP cohort reported that
25.3% of Irish women with GDM in their cohort met the meta-
bolic syndrome criteria compared to 6.6% of those with nor-
mal glucose during pregnancy in an average 3 years
postpartum [23]. The prevalence of the metabolic syndrome
of Danish women with previous GDM was threefold higher
than that in the general population (44% vs. 15%) in 9.8 years
postpartum [24]. When in a rather shorter postpartum period
(3 months), the risk of the metabolic syndrome was reported
to be twofold higher in women with GDM compared with
the control population of normal glucose during pregnancy
Fig. 1 – Flow chart of the study design.
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8.9%) [25]. Although postpartum OGTT were all used in the
studies above to assess the glucose tolerance, the relatively
small sample size in both women with GDM and without
GDM might limit the statistical power. In the present study,
we also used OGTT to assess the glucose tolerance for further
diagnosis of metabolic syndrome among Chinese women
with and without GDM. In addition, we used the logistic
regression model to accurately evaluate the risks of postpar-
tum metabolic syndrome among women with and without
GDM by adjusting for multiple confounding factors rather
than simply reporting an incidence rate.
In a recent meta-analysis, women with a history of GDM
showed a significantly higher risk of metabolic syndrome
than those without GDM with an odds ratio of 3.96, which
was similar to the odds ratio in our study [26]. However, this
meta-analysis reported that no association was found in
Asians in their subgroup analysis. Our study has provided
strong evidence that Chinese women with GDM also suffered
high risks of postpartum metabolic syndrome as the Cau-
casians did. The prevalence of diabetes and prediabetes
among Chinese adults was reported to be 10.9% and 35.7%
in 2013 [22]. In Asian populations, especially in Chinese,impaired glucose tolerance was found more prevalent than
impaired fasting glucose [21,22], which indicated that only
fasting glucose included into the criteria of metabolic syn-
drome would inevitably cause missing diagnosis of patients
with isolated impaired glucose tolerance. In this case, we
used the modified criteria including the postprandial hyper-
glycemia, which might be more practical in reflecting the
metabolic status among these women.
In our subgroups analysis, GDM women who were older
than 30 years vs younger than 30 years at delivery and who
were older vs younger than 35 years in the postpartum survey
seemed to have relatively higher risks of metabolic syndrome
compared with non-GDM women. It was interesting that
either pre-pregnancy or postpartum normal weight (BMI
lower than 25 kg/m2) GDM women would have relatively
higher risks of postpartum metabolic syndrome than either
pre-pregnancy or postpartum overweight GDM women. It
might be explained by the fact that BMI was not well matched
between women with GDM and without GDM (both pre-
pregnancy and postpartum BMIs were higher in women with
GDM than those without). However, these results might also
indicate that although overweight was a definite risk factor
for metabolic disorders, GDM women with normal weight
Table 1 – Characteristics of women with and without gestational diabetes (GDM), Tianjin, China.
Non-GDM GDM P
No. of participants 705 1263
Age at delivery, years 29.7 ± 2.83 30.1 ± 3.50 0.008
Duration after delivery, years 5.74 ± 1.19 3.65 ± 2.17 <0.001
Weight gain during pregnancy, kg 18.3 ± 6.67 16.8 ± 5.99 <0.001
Prepregnancy body mass index, kg/m2 21.4 ± 2.97 23.1 ± 3.32 <0.001
Postpartum body mass index, kg/m2 22.9 ± 3.68 24.3 ± 3.96 <0.001
Waist circumference, cm 75.8 ± 8.26 80.6 ± 9.48 <0.001
Fasting glucose, mmol/l 5.23 ± 0.52 5.43 ± 0.99 <0.001
2 h glucose, mmol/l 6.14 ± 1.41 7.24 ± 2.65 <0.001
HbA1c, mmol/mol 35 ± 3 38 ± 8 <0.001
HbA1c, % 5.3 ± 0.2 5.6 ± 0.7 <0.001
Education <0.001
<13 years 10.4 22.5
13-16 years 75.5 70.1
16 years 14.2 7.4
Income <0.001
<5000 yuan per month 5.4 27.5
5000-8000 yuan per month 15.5 36.9
8000 yuan per month 79.1 35.6
Family history of diabetes, % 27.1 35.7 <0.001
Current smoking, % 4.0 2.5 0.355
Passive smoking, % 55.2 58.0 0.572
Current alcohol drinker, % 32.1 26.9 <0.001
Leisure time physical activity, minutes/day <0.001
0 61.7 71.7
1-29 33.8 25.3
30 4.5 3.0
Sleeping time, hours/day 7.48 ± 0.95 7.70 ± 1.02 <0.01
Energy consumption, kcal/day* 1627 ± 381 1704 ± 432 0.01
Fiber, g/day 11.6 ± 4.42 12.3 ± 4.62 0.01
Fat, % energy 31.1 ± 5.65 33.1 ± 6.12 <0.001
Carbohydrate, % energy 52.3 ± 6.81 50.2 ± 7.04 <0.001
Protein, % energy 16.6 ± 2.62 16.7 ± 2.68 0.006
Sweetened beverage drink, % 77.9 78.1 0.223
* Dietary intakes were assessed by 3-day 24-h food records.
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Early postpartum lifestyle interventions are applicable for
both overweight and normal weight women with GDM to pre-
vent future metabolic disorders, especially for type 2 diabetes.
Several advantages may help enhance the conclusions of
the present study, including the diagnoses of GDM at 26–30
gestational weeks based on the whole population’s GDM uni-
versal screening by using the WHO’s criteria after a 2 h 75 g
OGTT, a relatively large sample size of GDM and non-GDM,
and the comprehensive postpartum screening for anthropo-
metric and lab measurements. Limitations in this study
included the relatively lower return rate of the first invitation
or else we would have an even larger sample size. Despite the
lower return rate, the demographic and laboratory character-
istics were similar between those returned and not returned
including age, 2 h glucose, fasting glucose, the prevalence of
IGT and diabetes at 26–30 gestational weeks, and OGTT tests.
However, whether other differences between these two
groups existed cannot be verified. Secondly, the 1-h glucose
and 3-h glucose during pregnancy were lacking since we used
the WHO criteria of GDM. Finally, most of the women in our
study only had a parity due to the one-child policy in China,
which might contribute to some restrictions in the general-
ization of the results.In conclusion, our study demonstrated that Chinese
women with GDM had 3–4 fold higher risks of metabolic syn-
drome at the first 3–4 years postpartum compared with
women without GDM. Metabolic profiles including central
obesity, hypertriglyceridemia, and high blood pressure other
than postprandial hyperglycemia were also highly found
among women with GDM. This study provided evidence that
women with GDM would have a higher risk of metabolic dis-
orders in their later life. Early lifestyle interventions might
help prevent type 2 diabetes and metabolic syndrome in both
overweight and normal weight women with GDM.
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Table 2 – Odds ratios of postpartum metabolic syndrome and its components among women with and without GDM.
NCEP-ATP III criteria IDF criteria
Non-GDM GDM Non-GDM GDM
No. of participants 705 1263 705 1263
Central obesity
No. of cases 189 630 189 630
Multiple adjusted odds ratios
Model 1 1 2.70 (2.21–3.30) 1 2.70 (2.21–3.30)
Model 2 1 2.64 (1.75–3.98) 1 2.64 (1.75–3.98)
Hypertriglyceridemia
No. of cases 42 204 41 194
Multiple adjusted odds ratios
Model 1 1 3.04 (2.15–4.30) 1 2.94 (2.07–4.18)
Model 2 1 4.14 (2.21–7.75) 1 3.68 (1.94–6.97)
Low HDL cholesterol
No. of cases 224 532 224 532
Multiple adjusted odds ratios
Model 1 1 1.60 (1.31–1.94) 1 1.60 (1.31–1.94)
Model 2 1 1.32 (0.89–1.96) 1 1.32 (0.89–1.96)
High blood pressure
No. of cases 39 144 39 144
Multiple adjusted odds ratios
Model 1 1 2.13 (1.48–3.08) 1 2.13 (1.48–3.08)
Model 2 1 3.60 (1.79–7.25) 1 3.60 (1.79–7.25)
Hyperglycemia
No. of cases 167 350 167 350
Multiple adjusted odds ratios
Model 1 1 1.23 (0.99–1.52) 1 1.23 (0.99–1.52)
Model 2 1 1.24 (0.80–1.92) 1 1.24 (0.80–1.92)
Hyperglycemia (modified)*
No. of cases 205 484 205 484
Multiple adjusted odds ratios
Model 1 1 1.51 (1.24–1.84) 1 1.51 (1.24–1.84)
Model 2 1 1.62 (1.08–2.44) 1 1.62 (1.08–2.44)
Metabolic syndrome
No. of cases 48 256 46 244
Multiple adjusted odds ratios
Model 1 1 3.46 (2.50–4.79) 1 3.40 (2.45–4.73)
Model 2 1 3.66 (2.02–6.63) 1 3.90 (2.13–7.14)
Metabolic syndrome (modified)
No. of cases 59 299 55 281
Multiple adjusted odds ratios
Model 1 1 3.40 (2.53–4.57) 1 3.37 (2.48–4.57)
Model 2 1 3.86 (2.22–6.73) 1 3.77 (2.13–6.67)
NCEP-ATP III: National Cholesterol Education Program Adult Treatment Panel III; IDF: International Diabetes Federation.
Model 1 adjusted for age only; Model 2 adjusted for age, postpartum years, weight gain during pregnancy, education, family income, family history
of diabetes, current smoking, passive smoking, current alcohol drinking, leisure time physical activity, sleeping time, energy consumption, fiber,
fat, protein and carbohydrate consumption, and sweetened beverage drinking.
* Modified hyperglycemia was defined as either fasting glucose 5.6 mmol/l or 2-h glucose 7.8 mmol/l or using glucose-lowering agents.
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